Filing Details

Accession Number:
0001209191-11-003244
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-14 16:35:57
Reporting Period:
2011-01-13
Filing Date:
2011-01-14
Accepted Time:
2011-01-14 16:35:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247015 J Sol Barer C/o Celgene Corporation
86 Morris Avenue
Summit NJ 07901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-13 108,534 $26.35 767,392 No 4 M Direct
Common Stock Disposition 2011-01-13 75,200 $57.38 692,192 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-01-13 108,534 $0.00 108,534 $26.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-01-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 61,281 Indirect 401(k) Plan
Footnotes
  1. This sale was executed pursuant to a prearranged trading plan compliant with Rule 10b5-1.
  2. The option was fully exercisable.
  3. The option was issued pursuant to the Company's 2008 Stock Incentive Plan.